




Searching News Database: erythropoiesis
HSMN NewsFeed - 28 Jan 2020
John Quisel, JD, PhD Joins Disc Medicine as President and Chief Executive Officer
John Quisel, JD, PhD Joins Disc Medicine as President and Chief Executive Officer
HSMN NewsFeed - 19 Feb 2015
Merganser Biotech Inc. Raises $28 Million in a Series A Financing to Develop Hepcidin Mimetic Peptides
Merganser Biotech Inc. Raises $28 Million in a Series A Financing to Develop Hepcidin Mimetic Peptides
HSMN NewsFeed - 16 Oct 2013
Akebia Appoints Jason A. Amello as Senior Vice President, Chief Financial Officer and Treasurer
Akebia Appoints Jason A. Amello as Senior Vice President, Chief Financial Officer and Treasurer
HSMN NewsFeed - 28 Aug 2013
Akebia Appoints Renal Industry Veteran John P. Butler as President and CEO
Akebia Appoints Renal Industry Veteran John P. Butler as President and CEO
HSMN NewsFeed - 20 Jan 2010
Medco to Advance Cancer Care with Personalized and Specialized Treatment for Oncology Patients
Medco to Advance Cancer Care with Personalized and Specialized Treatment for Oncology Patients
HSMN NewsFeed - 8 Mar 2008
Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa)
Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa)
HSMN NewsFeed - 7 Mar 2008
Amgen Announces Update to U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
Amgen Announces Update to U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
HSMN NewsFeed - 7 Dec 2007
Amgen in Discussions with FDA to Update U.S. Prescribing Information for ESAs
Amgen in Discussions with FDA to Update U.S. Prescribing Information for ESAs
HSMN NewsFeed - 8 Nov 2007
Ortho Biotech to Submit Official Request for Reconsideration to CMS Regarding ESA Coverage Policy
Ortho Biotech to Submit Official Request for Reconsideration to CMS Regarding ESA Coverage Policy
HSMN NewsFeed - 27 Sep 2007
Amgen Receives Proposal for Amending EU Prescribing Information for Aranesp(R)
Amgen Receives Proposal for Amending EU Prescribing Information for Aranesp(R)
HSMN NewsFeed - 11 Sep 2007
Amgen to Review Benefits, Risks of ESA Therapy in Chronic Renal Failure Patients at FDA Advisory Committee
Amgen to Review Benefits, Risks of ESA Therapy in Chronic Renal Failure Patients at FDA Advisory Committee
HSMN NewsFeed - 19 Apr 2007
Aranesp(R) ``145 Study'' Shows No Difference in Survival in Patients with Small-Cell Lung Cancer
Aranesp(R) ``145 Study'' Shows No Difference in Survival in Patients with Small-Cell Lung Cancer
HSMN NewsFeed - 9 Mar 2007
Ortho Biotech Revises Prescribing Information for PROCRIT(R) (Epoetin alfa)
Ortho Biotech Revises Prescribing Information for PROCRIT(R) (Epoetin alfa)
HSMN NewsFeed - 9 Mar 2007
Amgen Announces Update To U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
Amgen Announces Update To U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
HSMN NewsFeed - 1 Feb 2007
Fresenius Medical Care and Amgen Enter New Commercial Collaboration in Europe
Fresenius Medical Care and Amgen Enter New Commercial Collaboration in Europe
HSMN NewsFeed - 8 Dec 2006
49 Abstracts Evaluating Revlimid(R) To Be Presented at The 48th American Society of Hematology Meeting
49 Abstracts Evaluating Revlimid(R) To Be Presented at The 48th American Society of Hematology Meeting
HSMN NewsFeed - 19 Oct 2006
Fresenius Medical Care Announces New Sourcing and Supply Agreement with Amgen
Fresenius Medical Care Announces New Sourcing and Supply Agreement with Amgen
Additional items found! 16

Members Archive contains
16 additional stories matching:
erythropoiesis
(Password required)
erythropoiesis
(Password required)